Category: Neurological

Neurological

CureDuchenne Launches Supplemental Newborn Screening Initiative

CureDuchenne has launched a supplemental newborn screening initiative for Duchenne muscular dystrophy, in partnership with Brigham and Women's Hospital.

Neurological

‘Zombie Cells’ Light the Way to Spinal Cord Injury Repair

Administration of drugs that target specific cellular components of the scar that forms after spinal cord injury could help improve functional recovery after the injury, researchers suggest in Cell Reports.

Neurological

FSHD Society Opens Research Congress

The FSHD Society announces the opening of its 28th annual International Research Congress (IRC), which is being conducted entirely online.

For Some, It’s a Long Road to Stroke Care

by Debbie Overman | Jun 12, 2021 | Stroke

Race, age, income and health insurance status are factors in the distance patients must travel to reach the nearest certified stroke care, according to a nationwide analysis of US census data and road maps, published in Stroke.

BioAxone BioSciences Receives Notice of Allowance for Patent Regarding Its SCI Treatment Method

by Debbie Overman | Jun 10, 2021 | Company News, Spinal Cord Injury

BioAxone BioSciences Inc has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO), relating to its compound targeting transient PTEN suppression for nerve regeneration and the reduction of paralysis in SCI patients.

Cerebral Palsy Rehab for Kids Gets a Wii Boost

by Debbie Overman | Jun 10, 2021 | Cerebral Palsy, Fitness & Sports Medicine

Therapy based on the Nintendo Wii Balance Board could help improve balance in children with cerebral palsy, according to an analysis published in Developmental Medicine & Child Neurology.

Motor Neurons from ALS Patients Point to Potential Treatments

by Debbie Overman | Jun 9, 2021 | ALS, Research

Researchers at Boston Children’s Hospital, working in collaboration with Pfizer, report a high-throughput target and drug discovery platform using motor neurons made from ALS patients.

If You’re Broke, Don’t Have a Stroke

by Debbie Overman | Jun 8, 2021 | Stroke

Stroke survivors who live in neighborhoods with lower socioeconomic status may have worse recovery 3 months after a stroke than people who live in neighborhoods with higher socioeconomic status, according to a study published recently in Neurology.

Key Opinion Leader Webinar Regarding ALS Treatment, June 11

by Debbie Overman | Jun 8, 2021 | ALS, Webcasts and Webinars

Coya Therapeutics Inc will host a key opinion leader (KOL) webinar on ALS001, the company’s lead asset for the treatment of amyotrophic lateral sclerosis (ALS), on Friday, June 11, 2021 at 11:30 am ET.

MLB Fan Battling ALS Receives a Customized Power Wheelchair During Lou Gehrig Day

by Debbie Overman | Jun 8, 2021 | ALS, Company News, Power Wheelchairs

In partnership with the Pittsburgh Pirates, LiveLikeLou, and Phi Delta Theta, the Permobil Foundation gave a surprised fan a team-branded, custom Permobil power wheelchair at the Pirates home game on June 3.

FDA Approves SenSight Directional Lead System for DBS Therapy

by Debbie Overman | Jun 7, 2021 | Parkinson’s Disease

Medtronic plc announces the US Food and Drug Administration (FDA) approval and first US implants of the SenSight Directional Lead System used for Deep Brain Stimulation (DBS) therapy.

This Could Help Predict Aphasia Recovery in Bilingual Patients

by Debbie Overman | Jun 7, 2021 | Stroke, Traumatic Brain Injury

Researchers from Boston University suggest they can predict how well a patient will recover from aphasia using computer modeling.

If You Have OCD, Do This to Lessen Your Stroke Risk

by Debbie Overman | Jun 3, 2021 | Research, Stroke

Adults who have obsessive-compulsive disorder (OCD) were more than three times as likely to have an ischemic stroke later in life compared to adults who do not have OCD, according to new research published in Stroke, a journal of the American Stroke Association, a division of the American Heart Association.

ALS Biomarkers is Focus of New Xtalks Webinar

by Debbie Overman | Jun 3, 2021 | ALS, Webcasts and Webinars

Xtalks hosts the live webinar “ALS Biomarkers in Drug Development,” on Tuesday, June 22, 2021 at 11am EDT (4pm BST/UK).

Could Loss of Connection Trigger ALS?

by Debbie Overman | Jun 2, 2021 | ALS, Research

The network connection between nerve cells in the spinal cord seems to play a critical role in the development of the severe disease ALS, researchers suggest, in a new study published in Nature Communications.

ALS That Affects Children

by Debbie Overman | Jun 1, 2021 | ALS

An international team of researchers led by scientists at the National Institutes of Health and the Uniformed Services University (USU) report they have discovered a new and unique form of amyotrophic lateral sclerosis (ALS) that affects children.

Walking – Not Just Standing – Could Help Enhance Bowel Function This Way

by Debbie Overman | Jun 1, 2021 | Exoskeletons, Spinal Cord Injury

Physical intervention plans that included exoskeleton-assisted walking helped people with spinal cord injury evacuate more efficiently and improved the consistency of their stool, researchers from Kessler Foundation and others suggest, in Journal of Clinical Medicine.

2 Reasons Adults With CP Are Short-Changed on PT Services

by Debbie Overman | May 28, 2021 | Cerebral Palsy, Research

Adults with cerebral palsy are more likely to experience musculoskeletal disorders, but they receive significantly less physical therapy for those ailments, according to a recent study from Michigan Medicine, the university’s Health Lab reports.